产品
编 号：F058074
分子式：C5H10N2O7P2
分子量：272.09
分子式：C5H10N2O7P2
分子量：272.09
产品类型
规格
价格
是否有货
50mg
询价
询价
100mg
询价
询价
结构图
CAS No: 118072-93-8
产品详情
生物活性：
Zoledronic Acid (Zoledronate) is a third-generation bisphosphonate (BP), with potent anti-resorptive activity. Zoledronic Acid inhibits the differentiation and apoptosis of osteoclasts. Zoledronic Acid also has anti-cancer effects.
体内研究：
Zoledronic Acid (0.05 mg/kg; i.p.; weekly; for 3 weeks) increases bone mineral density and content.Zoledronic Acid (0.5-1 mg/kg; i.p.; weekly; for 3 weeks) inhibits both osteoclast and osteoblasts function and bone remodeling in vivo interfering with bone mechanical properties.Animal Model:Five-week-old C57BL6 mice
Dosage:0.05 mg/kg, 0.5 mg/kg, 1 mg/kg
Administration:Intraperitoneal injection, weekly, for 3 weeks
Result:Inhibited both osteoclast and osteoblasts function and bone remodeling at 0.5 mg/kg and 1 mg/kg.
体外研究：
Zoledronic Acid (0.1-1 μM; 48 hours) increases receptor activator of nuclear factor kB ligand (RANKL) and sclerostin mRNA expressions in osteocyte-like MLO-Y4 cells.Zoledronic Acid increases the expression of osteoclastogenesis supporting factor from MLO-Y4 cells.Zoledronic Acid enhances the RANKL expression via IL-6/ JAK2/STAT3 pathway in MLO-Y4 cells.Zoledronic acid inhibits osteoclast differentiation and function through the regulation of NF-κB and JNK signalling pathways.Zoledronic Acid (10-100 μM; 1-7 days) markedly reduces the viability of MC3T3-E1 cells.Zoledronic Acid (10-100 μM; 1-7 days) induces apoptosis in MC3T3-E1 cells.Zoledronic Acid (10-100 μM; 4 days) inhibits cell viability due to the induction of apoptosis.Zoledronic Acid exerts inhibitory effects on the differentiation and maturation of MC3T3-E1 cells at concentrations Zoledronic Acid 相关抗体:Cell Viability AssayCell Line:MC3T3-E1 cells
Concentration:0.01 μM , 0.1 μM, 1 μM, 10 μM, 100 μM
Incubation Time:1 day, 3 days, 5 days, 7 days
Result:Reduced cells viability at 10 μM and 100 μM.
Apoptosis AnalysisCell Line:MC3T3-E1 cells
Concentration:0.01 μM , 0.1 μM, 1 μM, 10 μM, 100 μM
Incubation Time:1 days, 4 days, 7 days
Result:Increased the number of early apoptotic cells and late apoptotic or necrotic cells at dose-dependent and time-dependent (high concentrations).
Western Blot AnalysisCell Line:MC3T3-E1 cells
Concentration:0.01 μM , 0.1 μM, 1 μM, 10 μM, 100 μM
Incubation Time:4 days
Result:Down-regulated the protein level of inactive caspase-3 and up-regulated the protein level of active caspase-3 at the concentrations of 10 and 100 μM.
Zoledronic Acid (Zoledronate) is a third-generation bisphosphonate (BP), with potent anti-resorptive activity. Zoledronic Acid inhibits the differentiation and apoptosis of osteoclasts. Zoledronic Acid also has anti-cancer effects.
体内研究：
Zoledronic Acid (0.05 mg/kg; i.p.; weekly; for 3 weeks) increases bone mineral density and content.Zoledronic Acid (0.5-1 mg/kg; i.p.; weekly; for 3 weeks) inhibits both osteoclast and osteoblasts function and bone remodeling in vivo interfering with bone mechanical properties.Animal Model:Five-week-old C57BL6 mice
Dosage:0.05 mg/kg, 0.5 mg/kg, 1 mg/kg
Administration:Intraperitoneal injection, weekly, for 3 weeks
Result:Inhibited both osteoclast and osteoblasts function and bone remodeling at 0.5 mg/kg and 1 mg/kg.
体外研究：
Zoledronic Acid (0.1-1 μM; 48 hours) increases receptor activator of nuclear factor kB ligand (RANKL) and sclerostin mRNA expressions in osteocyte-like MLO-Y4 cells.Zoledronic Acid increases the expression of osteoclastogenesis supporting factor from MLO-Y4 cells.Zoledronic Acid enhances the RANKL expression via IL-6/ JAK2/STAT3 pathway in MLO-Y4 cells.Zoledronic acid inhibits osteoclast differentiation and function through the regulation of NF-κB and JNK signalling pathways.Zoledronic Acid (10-100 μM; 1-7 days) markedly reduces the viability of MC3T3-E1 cells.Zoledronic Acid (10-100 μM; 1-7 days) induces apoptosis in MC3T3-E1 cells.Zoledronic Acid (10-100 μM; 4 days) inhibits cell viability due to the induction of apoptosis.Zoledronic Acid exerts inhibitory effects on the differentiation and maturation of MC3T3-E1 cells at concentrations Zoledronic Acid 相关抗体:Cell Viability AssayCell Line:MC3T3-E1 cells
Concentration:0.01 μM , 0.1 μM, 1 μM, 10 μM, 100 μM
Incubation Time:1 day, 3 days, 5 days, 7 days
Result:Reduced cells viability at 10 μM and 100 μM.
Apoptosis AnalysisCell Line:MC3T3-E1 cells
Concentration:0.01 μM , 0.1 μM, 1 μM, 10 μM, 100 μM
Incubation Time:1 days, 4 days, 7 days
Result:Increased the number of early apoptotic cells and late apoptotic or necrotic cells at dose-dependent and time-dependent (high concentrations).
Western Blot AnalysisCell Line:MC3T3-E1 cells
Concentration:0.01 μM , 0.1 μM, 1 μM, 10 μM, 100 μM
Incubation Time:4 days
Result:Down-regulated the protein level of inactive caspase-3 and up-regulated the protein level of active caspase-3 at the concentrations of 10 and 100 μM.
产品资料
Copyright©2015-2024 沪ICP备2022026524号-1
沪公网安备